Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2008 | 3 |
2009 | 2 |
2013 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.
Breast Cancer Res Treat. 2008 Sep;111(2):241-50. doi: 10.1007/s10549-007-9789-z. Epub 2007 Oct 23.
Breast Cancer Res Treat. 2008.
PMID: 17955362
The Effects of Indirubin-3'-Monoxime, A Novel AHR Ligand, on Stress and Toxicity-Related Gene/Protein Expression in Human U937 Cells Undergoing Differentiation and Activation.
Springs AE, Rice CD.
Springs AE, et al.
J Immunotoxicol. 2006 Jan 1;3(1):1-10. doi: 10.1080/15476910500468627.
J Immunotoxicol. 2006.
PMID: 18958680
Item in Clipboard
Mortality of rapid response team patients in Australia: a multicentre study.
ANZICS-CORE MET dose investigators.
ANZICS-CORE MET dose investigators.
Crit Care Resusc. 2013 Dec;15(4):273-8.
Crit Care Resusc. 2013.
PMID: 24289508
Item in Clipboard
Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC, Springs AE, Chen WY.
Jacquemart IC, et al. Among authors: springs ae.
Int J Oncol. 2009 Feb;34(2):517-28.
Int J Oncol. 2009.
PMID: 19148488
Item in Clipboard
Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/neu transgenic mice.
Tomblyn S, Springs AE, Langenheim JF, Chen WY.
Tomblyn S, et al. Among authors: springs ae.
Int J Oncol. 2009 Apr;34(4):1139-46. doi: 10.3892/ijo_00000242.
Int J Oncol. 2009.
PMID: 19287973
Item in Clipboard
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).
Kaplan BL, Springs AE, Kaminski NE.
Kaplan BL, et al. Among authors: springs ae.
Biochem Pharmacol. 2008 Sep 15;76(6):726-37. doi: 10.1016/j.bcp.2008.06.022. Epub 2008 Jul 8.
Biochem Pharmacol. 2008.
PMID: 18656454
Free PMC article.
Item in Clipboard
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE.
Springs AE, et al.
J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12.
J Leukoc Biol. 2008.
PMID: 18791168
Free PMC article.
Item in Clipboard
Cite
Cite